Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
KEY POINTS
People who receive Pfizer’s RSV vaccine for older adults should be monitored for Guillain-Barre syndrome, scientists said in an article published in the New England Journal of Medicine.
Two people who received the shot during vaccine trials developed the nervous system disorder.

Read more on:
https://www.cnbc.com/2023/04/06/rsv-adult-vaccine-pfizer-shot-monitored-for-guillain-barre.html